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guarantee a better sparing of normal tissue. Obtained index 
are aligned with reported results in analogous studies with 
Tomotherapy. Gammaknife perfexion seems to be the 
technique able to guarantee better results in term of CI. 
OARs sparing in case of no co-planar beam delivered by LINAC 
exhibit worse performance than modulated technique.  
 
Conclusion: Treatment of brain metastasis with Tomotherapy 
showed encouraging results in term of dosimetric outcome. 
Lesion size and prescription strategies showed a statistically 
significant influence on dosimetric distribution. Clinical 
outcome with frameless immobilization has proven feasible, 
well tolerated and able to increase patient compliance as 
exclusive treatment of brain oligo-MTS. 
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Purpose or Objective: It is challenging to achieve 
homogeneous target dose distribution in intensity-modulated 
radiotherapy (IMRT) for sinonasal cancer (SNC). To overcome 
this difficulty, we proposed a base-dose-compensation (BDC) 
planning technique, in which the treatment plan is further 
optimized based on the original plan with half of the 
prescribed number of fractions and finally the number of 
fractions of treatment plan was restored from a half to the 
total. 
 
Material and Methods: CT scan data of 13 patients were 
included. Generally acceptable original IMRT plans were 
created and further optimized individually by (1) the BDC 
technique and (2) a local-dose-control (LDC) planning 
technique, in which the original plan is further optimized by 
addressing hot and cold spots. We compared the target dose 
coverage, organ-at-risk (OAR) sparing, total planning time 
and monitor units (MUs) among the original, BDC, LDC IMRT 
plans and additionally generated volumetric modulated arc 
therapy (VMAT) plans. 
 
Results: The BDC technique provided significantly superior 
dose homogeneity/conformity by 23%-48%/6%-9% compared 
with both the original and LDC IMRT plans, as well as reduced 
doses to the OARs by up to 18%, with acceptable MU 
numbers. Compared with VMAT, BDC IMRT yielded superior 
homogeneity, inferior conformity and comparable overall 
OAR sparing. The planning of BDC, LDC IMRT and VMAT 
required 30, 59 and 58 minutes on average, respectively. 
 
Conclusion: The BDC planning technique can achieve 
significantly better dose distribution with shorter planning 
time in the IMRT for SNC. 
 
EP-1688  
Evaluation of automatic brain metastasis planning for 
multiple brain metastasis 
Y. Mori
1Aichi Medical University, Department of Radiology and 
Radiation Oncology, Aichi, Japan 
1 
 
Purpose or Objective: Recently Automatic Brain Metastasis 
Planning (ABMP) Element [BrainLAB] was commercially 
released by BrainLAB. It covers multiple off-isocenter targets 
at a time inside a multi-leaf collimator field and enables 
stereotactic radiosurgery (SRS) / stereotactic radiotherapy 
(SRT) with a single group of lineac-based dynamic conformal 
multi-arc for multiple brain metastases. In this study, dose 
planning of ABMP (ABMP-single isocenter dynamic conformal 
arc [ABMP-SIDCA]) for stereotactic radiosurgery of small 
multiple brain metastasis was evaluated in comparison with 
those of conventional multi-isocenter DCA (iPlan [BrainLAB]-
MIDCA) and Gamma Knife [Elekta] SRS (GKRS).  
 
Material and Methods: Simulation planning was performed 
with ABMP-SIDCA and GKRS was made in a case of multiple 
small brain metastasis (9 tumors of 0.2 to 0.7 ml in volume) 
which were originally treated with iPlan-MIDCA. First, 
dosimetric comparison was done between ABMP-SIDCA and 
iPan-MIDCA in the setting with PTV (planned target volume) 
margin of 2mm and D95=95% dose (19 Gy). Second, dosimetry 
of GKRS was compared with that of ABMP-SIDCA with PTV 
margin of 0, 1mm, and 2mm, and D95=100% dose (20 Gy). 
 
Results: First, CI (1/Paddick’s CI) and GI (V[half of 
prescription dose] / V[prescription dose]) in ABMP-SIDCA 
(mean, 1.36 and 5,12) were compatible with those of iPlan-
MIDCA (mean, 1.53 and 4.84). Second, PIV (prescription 
isodose volume) of GKRS (mean, 0.23 ml) was between that 
of no margin- and 1mm-margin ABMP-SIDCA (mean, 0.10 ml 
and 0.28 ml). Considering dose gradient, the same tendency 
was observed. The mean of V[half of prescription dose] of 
GKRS, no margin-, and 1 mm margin-ABMP-SIDCA were 0.87 
ml, 0.60 ml, and 1.37 ml respectively.  
 
Conclusion: The conformity and dose gradient with ABMP-
SIDCA was as good as those of conventional MIDCA by each 
lesion. If the conditions permit minimal PTV margin (1mm or 
less), ABMP-SIDCA might provide excellent dose fall-off 
compatible with GKRS and enable a short treatment time.  
The author has no COI. However this study was performed by 
use trial of ABMP Elements provided by BrainLAB (Tokyo). 
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Purpose or Objective: To determine in terms of target 
coverage and organ at risk (OAR) doses which concomitant 
boost technique is superior in the treatment of breast 
cancer; VMAT or fixed field IMRT. 
 
Material and Methods: 30 previously treated breast patients 
(15 Left, 15 Right) were re-planned with both VMAT and fixed 
field concomitant IMRT techniques. A two dose prescription 
was used similar to previous planning studies (1-3) using the 
same dose constraints as per the IMPORT HIGH trial (1). 40Gy 
in 15 fractions was planned to the whole breast while 
boosting the tumour bed to 48Gy in 15 fractions. A base plan 
consisting of the existing forward planned tangent fields 
delivered approximately 38Gy to the whole breast while the 
tumour bed was boosted with approximately 10Gy using an 
inverse planned IMRT option. A single partial arc starting and 
finishing at the tangent angles formed the VMAT portion and 
the ff-IMRT trial used the 2 existing tangent beam angles 
followed by 3 further equally spaced beams. Target 
coverage, heart, ipsilateral lung, contralateral lung and 
contralateral breast dose was measured. A Two-tailed t-Test 
sample for means was used to compare the dosimetric 
differences between the techniques using excel software. 
Statistical significance was defined as P<0.05. 
 
Results: Maximum dose D2% was statistically lower for VMAT; 
103.2% vs. 103.7% for ff IMRT whereas minimum doses were 
equivalent. No differences were found with ipsilateral lung 
mean and V5Gy doses, contralateral breast mean dose, heart 
mean dose, heart V5Gy and V10Gy doses. VMAT demonstrated 
statistically lower V2Gy doses to the contralateral lung (0.7% 
vs.1.6%) and heart for both left (19.0%/22.6%), and right 
(5.5%/8.8%) sided patients respectively. Whereas ff-IMRT 
boasted significantly lower ipsilateral lung V20Gy, V18Gy and 
V10Gy doses (7.9/8.6/13.1 vs. 8.1/8.8/13.4%) with VMAT 
respectively 
 
Conclusion: Despite both VMAT and ff-IMRT plans reaching 
statistical significance in a number of OAR and target 
parameters there is no clear superior option and whether the 
differences are clinically significant is a different question. 
Both techniques met all mandatory dose constraints and the 
